PointClickCare Revolutionizes Parkinson’s Disease Psychosis Diagnosis with Innovative Screening Tool
Summary
Given challenging diagnosis factors and how prevalent PD is, PointClickCare saw an urgent need to help senior care providers easily diagnose accompanying psychosis. In addition to enabling earlier diagnosis, the screener tool will facilitate a more standardized care process for this disease, allowing the industry to collect better data that can ultimately lead to better outcomes. “Not only will the screener tool better enable faster diagnosis, it will provide the senior care industry with a consistent way of approaching Parkinson’s Psychosis,” said Bill Stuart, Clinical Product Strategist, PointClickCare. “Parkinson’s Psychosis impacts many older people worldwide, and we’re thrilled to play a role in enabling earlier detection so that patients can receive the treatment they need sooner,” said ASCP’s chief executive, Chad Worz, PharmD, BCGP. Over 21,000 skilled nursing facilities, senior living communities, and home health agencies use PointClickCare today, making it the North American healthcare IT market leader for the LTPAC industry.
Classifications
AskAI Classifications
LabelsLinked Companies
